Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Zevra CEO drafts big ambitions for Miplyffa's US adoption curve
With Miplyffa, Zevra's CEO wants to transform the American treatment landscape for Niemann-Pick disease type C into one resembling Europe’s.
Fraiser Kansteiner
Jun 3, 2026 11:17am
Gilead expanding access to Yescarta, Tecartus with Cencora deal
Jun 3, 2026 11:11am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
FDA posts untitled letter for emails with eye-catching graphics
Jun 3, 2026 4:22am
Marilyn Monroe profiled in endometriosis awareness push
Jun 2, 2026 3:58pm
Fierce Biotech
Roche oral SERD's 1st-line miss spurs new adjuvant trial
Jun 2, 2026 12:45pm
More News
Fierce Healthcare
Eli Lilly to hospitals: Send 340B claims data or lose discounts
Jun 2, 2026 12:00pm
Merck lays off 88 staffers tied to New Jersey headquarters
Jun 2, 2026 11:10am
With trial success, Gilead paves way for broader use of Livdelzi
Jun 2, 2026 10:55am
Merck eyes COVID antiviral Lagevrio amid Ebola outbreak
Jun 2, 2026 10:40am